• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素和癌症发展中 ERα36 在细胞类型特异性功能中的作用。

The role of ERα36 in cell type-specific functions of estrogen and cancer development.

机构信息

Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Pharmacol Res. 2021 Jan;163:105307. doi: 10.1016/j.phrs.2020.105307. Epub 2020 Nov 25.

DOI:10.1016/j.phrs.2020.105307
PMID:33246174
Abstract

Exploring the regulatory effects of estrogen on different body organs via its receptors is largely of interest. Recently, the expression, signaling and the clinical significance of ERα36, the newly identified isoform of ERα, mediating non-genomic signaling of estrogen, have been studied in a wide range of organs and tumors. ERα36 is expressed highly in the CNS and actively involved in neuroprotection. It is also suggested to be an important estrogen receptor involved in preserving bone in postmenopausal women. On the oncological side, although ERα36 has usually been considered to be an oncogenic molecule, results from some studies paradoxically imply its protective role in certain tumors. Collectively, it seems that ERα36 is highly involved in cell type-specific functions of estrogen through its MAPK/ERK signaling, which is dependent on ERα36 expression levels, ligand concentrations and disease stage. The response is also dependent on the levels of ERα66 and ERβ. These factors influence the ERK kinetic and determine the ultimate mitogenic or antimitogenic signaling of estrogen, leading to cell survival or cell death. In this review, we summarize the recent organ-specific, cellular and molecular events and the mechanisms involved in estrogen effects mediated through the ERα36/ ERα66 with a particular focus on carcinomas where more clinical information has recently emerged.

摘要

研究雌激素通过其受体对不同身体器官的调节作用具有重要意义。最近,在广泛的器官和肿瘤中研究了 ERα36(新鉴定的 ERα 同工型)的表达、信号转导及其在非基因组雌激素信号转导中的临床意义。ERα36 在中枢神经系统中表达水平较高,积极参与神经保护。它也被认为是参与绝经后妇女保护骨骼的重要雌激素受体。在肿瘤学方面,尽管 ERα36 通常被认为是致癌分子,但一些研究的结果却出人意料地暗示了它在某些肿瘤中的保护作用。总的来说,通过其 MAPK/ERK 信号转导,ERα36 似乎高度参与了雌激素对特定细胞类型的功能,这取决于 ERα36 的表达水平、配体浓度和疾病阶段。这种反应还取决于 ERα66 和 ERβ 的水平。这些因素影响 ERK 的动力学,并决定了雌激素的最终有丝分裂或抗有丝分裂信号,导致细胞存活或细胞死亡。在这篇综述中,我们总结了最近在器官特异性、细胞和分子事件以及通过 ERα36/ERα66 介导的雌激素作用的机制方面的研究进展,特别关注了最近出现更多临床信息的癌。

相似文献

1
The role of ERα36 in cell type-specific functions of estrogen and cancer development.雌激素和癌症发展中 ERα36 在细胞类型特异性功能中的作用。
Pharmacol Res. 2021 Jan;163:105307. doi: 10.1016/j.phrs.2020.105307. Epub 2020 Nov 25.
2
ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.雌激素受体α36- G 蛋白偶联受体 1 相互作用抑制乳腺癌细胞中 TLR4/NFκB 诱导的促炎活性。
Int J Mol Sci. 2021 Jul 16;22(14):7603. doi: 10.3390/ijms22147603.
3
17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.17β-雌二醇通过调节雌激素受体亚型与雄激素受体的相对比值抑制睾酮诱导的 HepG2 细胞增殖。
J Cell Biochem. 2018 Nov;119(10):8659-8671. doi: 10.1002/jcb.27111. Epub 2018 Jul 30.
4
Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention.揭示雌激素的潜力:探索其在神经精神疾病和运动干预中的作用。
Pharmacol Res. 2024 Jun;204:107201. doi: 10.1016/j.phrs.2024.107201. Epub 2024 May 3.
5
Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.催乳素垂体腺瘤中 ERα66 及其新型变异异构体 ERα36 的表达模式及其与临床病理特征的关联。
Pituitary. 2020 Jun;23(3):232-245. doi: 10.1007/s11102-020-01029-z.
6
Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction.雌激素通过依赖 GPER 的 ERα36 诱导促进类精原细胞瘤 TCam-2 细胞系的增殖。
Mol Cell Endocrinol. 2012 Mar 5;350(1):61-71. doi: 10.1016/j.mce.2011.11.021. Epub 2011 Nov 25.
7
Role of ERα36 in membrane-associated signaling by estrogen.雌激素受体α36(ERα36)在雌激素膜相关信号传导中的作用
Steroids. 2014 Mar;81:74-80. doi: 10.1016/j.steroids.2013.10.020. Epub 2013 Nov 16.
8
The Role of ERα36 in Development and Tumor Malignancy.ERα36 在发育和肿瘤恶性肿瘤中的作用。
Int J Mol Sci. 2020 Jun 9;21(11):4116. doi: 10.3390/ijms21114116.
9
ERα36--Another piece of the estrogen puzzle.ERα36--雌激素之谜的又一块拼板。
Eur J Cell Biol. 2015 Dec;94(12):611-25. doi: 10.1016/j.ejcb.2015.10.001. Epub 2015 Oct 21.
10
The effects of estrogen on targeted cancer therapy drugs.雌激素对靶向癌症治疗药物的影响。
Pharmacol Res. 2022 Mar;177:106131. doi: 10.1016/j.phrs.2022.106131. Epub 2022 Feb 12.

引用本文的文献

1
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.解读胶质母细胞瘤:对胶质瘤生物学和治疗策略的基础与新见解
Curr Issues Mol Biol. 2024 Mar 13;46(3):2402-2443. doi: 10.3390/cimb46030153.
2
Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance.小分子抑制剂靶向 Hsp70-Bim 蛋白-蛋白相互作用,克服雌激素受体阳性乳腺癌对他莫昔芬的耐药性。
Breast Cancer Res. 2024 Feb 26;26(1):33. doi: 10.1186/s13058-024-01790-0.
3
Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis.
雌激素受体 ER-α36 在化疗治疗乳腺癌中的表达意义:一项荟萃分析。
Mol Biotechnol. 2024 May;66(5):991-999. doi: 10.1007/s12033-023-01029-x. Epub 2024 Jan 25.
4
The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells.YAP在雌激素受体α36(ERα36)介导的MCF-7乳腺癌细胞增殖及上皮-间质转化中的重要作用。
Front Pharmacol. 2022 Dec 2;13:1057276. doi: 10.3389/fphar.2022.1057276. eCollection 2022.
5
6,7-Dihydro-5-benzo[7]annulene Compounds as Selective Estrogen Receptor Degraders for Treating Cancer.6,7-二氢-5-苯并[7]轮烯化合物作为用于治疗癌症的选择性雌激素受体降解剂
ACS Med Chem Lett. 2022 Jul 4;13(7):1012-1013. doi: 10.1021/acsmedchemlett.2c00287. eCollection 2022 Jul 14.
6
Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms.前列腺癌中雌激素受体的分布和作用:相关的分子机制。
Front Endocrinol (Lausanne). 2022 Jan 11;12:811578. doi: 10.3389/fendo.2021.811578. eCollection 2021.
7
Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients.miR-338-5p启动子的高甲基化介导ETS-1的异常表达并与星形细胞瘤患者的疾病严重程度相关。
Front Oncol. 2021 Nov 11;11:773644. doi: 10.3389/fonc.2021.773644. eCollection 2021.
8
Lost but Not Least-Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer.虽已缺失但并非最不重要——雌激素受体阳性乳腺癌中孕激素受体缺失的新见解
Cancers (Basel). 2021 Sep 23;13(19):4755. doi: 10.3390/cancers13194755.
9
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.增强表皮生长因子受体抑制在三阴性乳腺癌中的治疗效果。
Pharmaceuticals (Basel). 2021 Jun 18;14(6):589. doi: 10.3390/ph14060589.
10
miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase.微小RNA-27-3p通过靶向γ-分泌酶的催化亚基早老素-1(PSEN-1)增强三阴性乳腺癌细胞对抗肿瘤药物奥拉帕尼的敏感性。
Front Oncol. 2021 Jun 8;11:694491. doi: 10.3389/fonc.2021.694491. eCollection 2021.